Skip to main content

Advertisement

Table 5 Discussion and conclusions about planning further studies

From: Questions asked and answered in pilot and feasibility randomized controlled trials

   Drug (n = 28) Non-drug (n = 22) P
Coverage of feasibility issues in the Discussion section none 8 (29%) 3 (14%) 0.0021
  minimal 9 (32%) 2 (9%)  
  substantial 9 (32%) 7 (32%)  
  major focus of section 2 (7%) 10 (46%)  
Extent of discussion or recommendations about planning future trials none 6 (21%) 1 (5%) 0.0021
  minimal 21 (75%) 13 (59%)  
  substantial 1 (5%) 8 (36%)  
  major focus of section 0 0  
One or more conclusion about methodological issues in a conclusions section 7/14 (50%) 16/18 (89%) 0.0223
One or more conclusion about methodological issues in the Abstract 5 (18%) 11 (50%) 0.0313
Conducting a subsequent trial or about to start one in the near future 3 (11%) 3 (14%) 1.0003
  1. 1 - Mann Whitney U test
  2. 2 - Restricted to papers with a Conclusions section
  3. 3 - Exact Pearson's chi-squared test